AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 17 filers reported holding AMBRX BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,979,730 | +48.4% | 606,933 | +112.4% | 0.00% | +100.0% |
| Q2 2023 | $4,702,885 | +1703843.8% | 285,716 | +822.0% | 0.00% | – |
| Q1 2023 | $276 | +541.9% | 30,989 | +64.9% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 18,793 | -83.5% | 0.00% | – |
| Q3 2022 | $123,000 | -54.8% | 113,692 | +10.6% | 0.00% | – |
| Q2 2022 | $272,000 | -36.7% | 102,776 | -1.6% | 0.00% | – |
| Q1 2022 | $430,000 | -51.6% | 104,429 | +6.1% | 0.00% | – |
| Q4 2021 | $889,000 | -53.4% | 98,419 | -30.4% | 0.00% | -100.0% |
| Q3 2021 | $1,909,000 | -32.4% | 141,431 | -1.8% | 0.00% | -50.0% |
| Q2 2021 | $2,824,000 | – | 144,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,932,591 | $5,121,000 | 0.71% |
| Cormorant Asset Management, LP | 2,486,386 | $6,589,000 | 0.50% |
| Artal Group S.A. | 2,152,291 | $5,704,000 | 0.30% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,491,832 | $3,953,000 | 0.15% |
| Octagon Capital Advisors LP | 122,800 | $325,000 | 0.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,027,291 | $5,372,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 19,063 | $51,000 | 0.00% |
| FMR LLC | 3,857,679 | $10,223,000 | 0.00% |
| Renaissance Technologies | 11,000 | $29,000 | 0.00% |
| UBS Group AG | 242 | $1,000 | 0.00% |